Loading
journalsJournal
Cancer biotherapy & radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals covers immunotherapy, targeted biological agents and radiolabelled drugs for cancer imaging and treatment, read by nuclear medicine and biotherapy researchers.
Also called: Cancer Biotherapy & RadiopharmaceuticalsCancer Biotherapy and RadiopharmaceuticalsCancer Biother Radiopharm
Overview
Cancer Biotherapy & Radiopharmaceuticals has been published since 1996 and, according to the NLM catalogue, is issued from 2026 by SAGE Publications in Thousand Oaks, California, following its long run with Mary Ann Liebert; Crossref lists SAGE Publications as the publisher. As its title indicates, its two subjects are cancer biotherapy, meaning biological agents used to treat cancer, and radiopharmaceuticals, meaning radiolabelled compounds used to image and treat it. The NLM record lists it as a United States serial that is indexed in MEDLINE; it is not listed in DOAJ.
Publisher
SAGE Publications (formerly Mary Ann Liebert)
Scope
cancer biotherapy and radiopharmaceuticals
Founded
1996
ISSN
1084-9785
Similar pages
- TreatmentIomab-B
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).
- TrialStudy of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).
- CompanyAbdera Therapeutics
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).
- TechnologyAuger-electron therapy
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).
- IdeaCAIX theranostics: 89Zr-girentuximab PET and 177Lu/225Ac-girentuximab therapy
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).
- RoadmapRadiopharmaceutical roadmap: iodine → lutetium → actinium
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).
- TechnologyTherapeutic isotope supply chain (Mo-99, Lu-177, Ac-225)
Shares Radio-antibody & radio-ADC, Radioligand therapy (beta emitters).